Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 1
2000 3
2001 3
2002 4
2003 2
2004 1
2005 3
2006 5
2007 10
2008 13
2009 13
2010 12
2011 16
2012 19
2013 35
2014 58
2015 63
2016 48
2017 35
2018 35
2019 35
2020 31
2021 68
2022 56
2023 64
2024 57
2025 58

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

638 results

Results by year

Filters applied: . Clear all
Page 1
Occupational interstitial lung diseases.
Spagnolo P, Ryerson CJ, Guler S, Feary J, Churg A, Fontenot AP, Piciucchi S, Udwadia Z, Corte TJ, Wuyts WA, Johannson KA, Cottin V. Spagnolo P, et al. Among authors: guler s. J Intern Med. 2023 Dec;294(6):798-815. doi: 10.1111/joim.13707. Epub 2023 Aug 7. J Intern Med. 2023. PMID: 37535448 Review.
Progression of fibrosing interstitial lung disease.
Wong AW, Ryerson CJ, Guler SA. Wong AW, et al. Among authors: guler sa. Respir Res. 2020 Jan 29;21(1):32. doi: 10.1186/s12931-020-1296-3. Respir Res. 2020. PMID: 31996266 Free PMC article. Review.
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities.
Spagnolo P, Ryerson CJ, Putman R, Oldham J, Salisbury M, Sverzellati N, Valenzuela C, Guler S, Jones S, Wijsenbeek M, Cottin V. Spagnolo P, et al. Among authors: guler s. Lancet Respir Med. 2021 Sep;9(9):1065-1076. doi: 10.1016/S2213-2600(21)00017-5. Epub 2021 Jul 28. Lancet Respir Med. 2021. PMID: 34331867 Review.
Response.
Guler SA, Scheschkowski T, Renner A, Kämpf L, Gasser M, Maurer B. Guler SA, et al. Chest. 2024 Oct;166(4):e132. doi: 10.1016/j.chest.2024.04.044. Chest. 2024. PMID: 39389702 No abstract available.
Corrigendum.
Guler S, Cimen S, Hu Q, Venkatachalam AB, Hart-Matyas M, Alwayn I. Guler S, et al. J Invest Surg. 2017 Oct;30(5):351. doi: 10.1080/08941939.2016.1274345. J Invest Surg. 2017. PMID: 28960113 Free article. No abstract available.
The Authors Respond.
Kocaşaban DÜ, Güler S. Kocaşaban DÜ, et al. Among authors: guler s. Am J Emerg Med. 2025 Jun;92:196-197. doi: 10.1016/j.ajem.2025.02.048. Epub 2025 Feb 28. Am J Emerg Med. 2025. PMID: 40055041 No abstract available.
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
Durand-Réville TF, Guler S, Comita-Prevoir J, Chen B, Bifulco N, Huynh H, Lahiri S, Shapiro AB, McLeod SM, Carter NM, Moussa SH, Velez-Vega C, Olivier NB, McLaughlin R, Gao N, Thresher J, Palmer T, Andrews B, Giacobbe RA, Newman JV, Ehmann DE, de Jonge B, O'Donnell J, Mueller JP, Tommasi RA, Miller AA. Durand-Réville TF, et al. Among authors: guler s. Nat Microbiol. 2017 Jun 30;2:17104. doi: 10.1038/nmicrobiol.2017.104. Nat Microbiol. 2017. PMID: 28665414
638 results